Showing 1,460 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

US Lawmakers Attack Cost of New Hepatitis Drug

Editor's pick
New York Times
24 March 2014
HIV prevention policy

NY deal with drug maker paves way for plan to end HIV

Editor's pick
Albany Times Union
20 March 2014
Pharmaceutical industry

Merck HIV Drug Strategy Seen Shielding Patent: Corporate India

Editor's pick
Bloomberg
20 March 2014
Pharmaceutical industry

Trouble Ahead for Gilead and Sovaldi?

Editor's pick
Motley Fool
19 March 2014
Pharmaceutical industry

How Much Should Hepatitis C Treatment Cost?

Editor's pick
New York Times (editorial)
18 March 2014
Pharmaceutical industry

Can Gilead Dominate The HIV Drug Market Again in 2014?

Editor's pick
Motley Fool
13 March 2014
Pharmaceutical industry

AbbVie Does Not Appeal 9th Circuit Heightened Scrutiny Ruling

Editor's pick
Poz magazine news
12 March 2014
Access to healthcare

Global community-based networks unite to demand pharmaceuticals lower the price of hepatitis C treatment

Editor's pick
GNP+
10 March 2014
Access to healthcare

Pharma refuses to ensure access to lifesaving hepatitis C treatment at global meeting

Editor's pick
Treatment Action Group
28 February 2014
Access to healthcare

Fighting For Global Access to Hepatitis C Therapies

Editor's pick
HepMag
19 February 2014
Hepatitis C treatment

Treating HCV -- Is the Price Right?

Editor's pick
Med Page Today
19 February 2014
Pharmaceutical industry

HIV/AIDS firms top new pharma reputation list

Editor's pick
PharmaTimes
14 February 2014
New & experimental hepatitis C treatment

Gilead's CEO Says New Hepatitis C Drug Attracts Payers

Editor's pick
Bloomberg Businessweek
13 February 2014
Pharmaceutical industry

Follows on “Pharmagate” plot: South Africa activists picket Merck office, while two drug companies leave pharmaceutical association

Editor's pick
Science Speaks
11 February 2014
New & experimental hepatitis C treatment

Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C

Editor's pick
Gilead press release
11 February 2014
New & experimental hepatitis C treatment

New hepatitis C pill lifts Gilead's 4Q sales

Editor's pick
Bloomberg Businessweek
7 February 2014
New & experimental hepatitis C treatment

Gilead to license hepatitis C drug to lower-cost manufacturers in India

Editor's pick
Reuters
6 February 2014
New & experimental HIV treatments

UK: Once-daily HIV pill Tivicay from ViiV gets launch

Editor's pick
Pharma Times
5 February 2014
New & experimental hepatitis C treatment

Abbvie Strong Hep C Drug Data and the Looming Battle With Gilead Sciences

Editor's pick
The Street
3 February 2014
Access to healthcare

At $84000 Gilead Hepatitis C Drug Sets Off Payer Revolt

Editor's pick
Bloomberg
27 January 2014
New & experimental hepatitis C treatment

Only just the beginning of the end of hepatitis C

Editor's pick
The Lancet (editorial)
26 January 2014
Pharmaceutical industry

Janssen Announces New Group Targeting Unmet Global Health Needs

Editor's pick
Janssen press release
22 January 2014
Pharmaceutical industry

Abbott Spinoff Faces New Trial on AIDS Drug Over Gay Juror Exclusion

Editor's pick
Bloomberg
22 January 2014
Access to healthcare

South African pharma firms accused of planning to delay patents law reform

Editor's pick
The Guardian
17 January 2014